Evidence map›Paper›PMID 32333584›Full record

ArticleJournal of Alzheimer's disease : JAD2020

Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline.

Ragna Espenes, Bjørn-Eivind Kirsebom, Cecilia Eriksson, Knut Waterloo, Erik Hessen, Stein Harald Johnsen, Per Selnes, Tormod Fladby

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Characteristics of subjective cognitive decline associated with amyloid positivity.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ragna EspenesDepartment of Neurology, University Hospital of North Norway, Tromsø, Norway.
Bjørn-Eivind KirsebomDepartment of Neurology, University Hospital of North Norway, Tromsø, Norway.
Cecilia ErikssonDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Knut WaterlooDepartment of Neurology, University Hospital of North Norway, Tromsø, Norway.
Erik HessenDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Stein Harald JohnsenDepartment of Neurology, University Hospital of North Norway, Tromsø, Norway.
Per SelnesDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
Tormod FladbyDepartment of Neurology, Akershus University Hospital, Lørenskog, Norway.
University Hospital of North Norway · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubjective cognitive decline (SCD) is associated with an increased risk of Alzheimer's disease (AD). However, patients reporting SCD to their general practitioner are not always referred to a memory clinic.

objectiveTo investigate whether prior history of medical help-seeking is associated with AD biomarker abnormality, worse cognitive performance, and/or depressive symptoms in SCD.

methodsWe compared levels of cerebrospinal fluid (CSF) Aβ1 - 42, cognitive performance, and depressive symptoms (15-item Geriatric Depression Scale, GDS-15) between healthy controls (n = 88), SCD with a history of medical help seeking (SCD-HS, n = 67), and SCD non help-seekers (SCD-NHS, n = 44). Cases with evidence of amyloid plaques (CSF Aβ1 - 42 ≤708 ng/l) and symptoms of depression (GDS-15≥6) were determined in both SCD groups.

resultsThe SCD-HS group had lower CSF Aβ1 - 42 (p < 0.01), lower word list learning and memory recall (p < 0.0001), and an increased level of depressive symptoms (p < 0.0001) compared to controls and SCD-NHS cases. The SCD-HS group had more cases with symptoms of depression (n = 12, 18%) and amyloid plaques (n = 18, 27%) compared to SCD-NHS (n = 1, 2% and n = 7, 16%, respectively). None of the SCD-HS cases and only one SCD-NHS case had concurrent symptoms of depression and amyloid plaques. The SCD-HS cases showed equal word list learning and memory performance regardless of amyloid status or symptoms of depression.

conclusionMedical help-seeking in SCD is associated with an increased risk of AD pathology or symptoms of depression. However, subtle memory deficits are seen in SCD help-seekers, also without amyloid plaques or symptoms of depression.

Indexed as

Help-Seeking BehaviorAgedAlzheimer DiseaseAmyloid beta-PeptidesCognitive DysfunctionDepressionFemaleHumansMalePeptide FragmentsPlaque, AmyloidRisk Factorstau ProteinsAmyloid beta-Peptidesamyloid beta-protein (1-42)MAPT protein, humanPeptide Fragmentstau ProteinsAlzheimer’s diseaseamyloid plaquescerebrospinal fluid Aβ1 - 42cognitive symptomsearly diagnosishelp-seeking behaviormedical help-seekingneuropsychiatric symptomsneuropsychological testssubjective cognitive decline

Identifiers

PMID32333584
PMCPMC7369054
OpenAlexW3018169512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.